BridgeBio Pharma 株価情報 (NASDAQ: BBIO)

最新ニュース BridgeBio Pharma (NASDAQ:BBIO) 株価情報

BridgeBio Pharma

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

BridgeBio Pharma Inc

LKQ Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>) shares were trading higher in the premarket session on Thursday after the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44973608/lkq-corporation-announces-results-for-first-quarter-2025" rel="noreferrer noopener">company released its first-quarter results.</a>
The company reported quarterly adjusted earnings per share of 79 cents, beating the analyst consensus estimate of 78 cents.
Revenues of $3.46 billion (down 6.5%&nbsp;year over year) missed the street view of $3.56 billion.
&#8220;We have formed a dedicated tariff task force comprised of leaders from across our global enterprise to proactively prepare for and navigate the potential opportunities or disruptions that could be caused by the ever-changing tariff landscape,&#8221; stated Justin Jude, President and Chief Executive Officer.
Also Read:<a target="_blank" href="https://www.benzinga.com/25/04/44965915/northrop-grummans-strategic-edge-lies-in-classified-space-and-electronic-warfare-programs-but-market-focused-on-short-term-issues-analyst" rel="noreferrer noopener"> Northrop Grumman&#8217;s Flight Path Recalculated: Analyst Trims Forecast, Reiterates Buy</a>
Quarterly gross margin increased to 39.8% from 39.2% year over year. Adjusted EBITDA in the quarter under review totaled $392 million, compared with $390 million in the year-ago period.
The company exited the quarter with cash and equivalents worth $227 million. Inventories totaled $3.361 billion at quarter end.
Dividend: On April&nbsp;22, the company declared a quarterly cash dividend of 30 cents per share of common stock, payable on May&nbsp;29, to stockholders of record at the close of business on May&nbsp;15.
Outlook:
LKQ affirms FY25 adjusted EPS guidance of $3.40-$3.70 versus the $3.54 estimate.
The firm also maintained the GAAP EPS Guidance of $2.91-$3.21 versus $3.12 estimate.
&#8220;We will update our guidance as necessary in future quarters when there is greater clarity regarding the tariff situation,&#8221;  stated Rick Galloway, senior vice president and chief financial officer.
Price Action: LKQ shares are trading higher by 2.52% to $43.19 premarket at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44957714/rogers-communications-q1-earnings-beat-expectations-reiterates-outlook" target="_blank" rel="noreferrer noopener">Rogers Communications Q1 Earnings Beat Expectations, Reiterates Outlook</a></li>
</ul>
Photo: Shutterstock

Earnings

Equities

News

Guidance

Markets

Movers

General

LKQ Edges Past Q1 EPS Estimates, Revenue Misses As Tariff Uncertainty Looms

Wells Fargo analyst Zachary Fadem maintains Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) with a Overweight and lowers the price target from $60 to $55.

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Chipotle Mexican Grill, Lowers Price Target to $55

LOBO, a fast-growing electric mobility manufacturer, is pleased to announce its intent to initiate a strategic cooperation in Indonesia with Green Gold Asia to launch a new line of innovative electric bike and tricycle. This move is a key milestone in LOBO's mission to expand globally and deliver accessible, green mobility to communities around the world.
Indonesia is one of the most promising markets for electric mobility, driven by rapid urbanization, a growing middle class, and strong national commitments to sustainable development. With a population of over 270 million and increasing demand for environmentally friendly transportation, Indonesia's EV market is projected to surpass $5 billion USD by 2030, with two- and three-wheel electric vehicles expected to lead adoption.
In this partnership, LOBO and Green Gold Asia—a local leader in sustainable development and market entry strategy—will combine their strengths to deliver tailored, high-quality electric vehicles supported by a reliable network of charging stations developed by GGA. According to the strategic agreement, the cooperation is expected to exceed $ 5 million USD in value in its first year, with a phased rollout across key metropolitan regions.
"This cooperation represents a powerful alignment of technology and local insight," said Mr. Huajian Xu, CEO of LOBO. "We believe sustainable mobility should be inclusive, affordable, and relevant to real-life needs. By working with Green Gold Asia, we are laying the foundation for long-term impact in one of Asia's most important markets."
Mr. Leonard Ho, CEO of Green Gold Asia, added: "LOBO brings the kind of visionary product innovation and global experience that complements our deep understanding of the Indonesian market. Together, we aim to fast-track the adoption of electric mobility and empower communities with smarter, cleaner transportation options."
LOBO and GGA's comprehensive solution spans from innovative electric vehicles to intelligent battery management and integrated charging infrastructure. The initiative will help Indonesia reduce carbon emissions, ease urban congestion, and offer practical, modern transport options to individuals and families alike.
This partnership is part of LOBO's broader international strategy, with further expansions planned across Southeast Asia, Latin America, and Africa in the coming year.

Contracts

LOBO

LOBO Announces Strategic Cooperation With Green Gold Asia In Indonesia's $5B+ EV Market  To Accelerate Global Expansion

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is increasingly being viewed in <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44906897/bitcoin-spikes-but-gold-surges-whats-driving-the-underperformance">the same league as gold</a> when it comes to long-term inflation hedging, according to John D'Agostino, Head of Strategy for Coinbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) Institutional.
What Happened: <a href="https://www.youtube.com/watch?v=ImJuCrL9p6g">Speaking</a> with CNBC as Bitcoin traded near $92,500 levels on Thursday morning, D'Agostino emphasized that Bitcoin has now earned a place next to gold in strategic asset allocations aimed at protecting capital during periods of financial stress.
"In every single one of their analysis, Bitcoin was top five," he said, referring to top global commodity traders who ran inflation hedge simulations. "Bitcoin and gold go side by side."
The statement comes amid heightened institutional interest in Bitcoin as a non-sovereign asset. 
D'Agostino noted that while retail investors have been exiting Bitcoin ETFs in April, institutional players, including sovereign wealth funds and insurance pools, were steadily accumulating directly. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44959727/trump-token-price-explodes-60-following-announcement-of-private-dinner-with-donald-trump">TRUMP Token Price Explodes 60% Following Announcement Of Private Dinner With Donald Trump</a>
This divergence in behavior coincided with a 13% rise in Bitcoin&#8217;s price, outpacing gold&#8217;s 10.5% during the same period.
"There's a very short list of assets that mirror the characteristics of gold," D'Agostino said, highlighting scarcity, immutability, portability, and non-sovereign status as core attributes shared by both assets.
He added that some investors, having missed the rally in gold, are now positioning in Bitcoin as a second inflation hedge. "You look at that rally and say, I missed the boat on that. What other assets could participate?"
What&#8217;s Next: While stressing that no asset is a perfect hedge, D'Agostino's comments reflect growing alignment in institutional strategy that views Bitcoin as a viable component of long-term inflation protection, especially as macro conditions like de-dollarization and geopolitical volatility evolve.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44959287/bitcoin-has-likely-bottomed-at-74500-200000-is-on-the-table-says-arthur-hayes">Bitcoin Has Likely Bottomed At $74,500, $200,000 Is On The Table, Says Arthur Hayes</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

COIN

Bitcoin, Gold Are Top Inflation Hedges, Says Coinbase's John D'Agostino

The market may be moody, but bargain hunters are <a href="https://www.benzinga.com/tech">treating Big Tech</a> like it is Black Friday in July.
Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>), Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) &#8211; the untouchables of the last bull run &#8211; have been hit by a cocktail of inflation worries, trade tension tantrums and AI-spending skepticism.
<h2 class="wp-block-heading">Big Tech Has Been Heavily Sold Off</h2>
But as Violeta Todorova, senior research analyst at Leverage Shares, notes, "Big technology companies with strong balance sheets and substantial cash reserves, such as Nvidia, Alphabet, Microsoft, Amazon, and Meta Platforms, have been heavily sold off, making them particularly attractive for those viewing the selloff as temporary and sentiment driven." Todorova shared her insights exclusively with Benzinga via email.
Read Also: <a href="https://www.benzinga.com/25/04/44921007/alphabets-75b-bet-too-significant-for-google-to-pull-back-now-says-jpmorgan">Alphabet&#8217;s $75 Billion Bet: &#8216;Too Significant For Google To Pull Back&#8217; Now, Says JPMorgan</a>
The culprits? Mounting "concerns around AI-related capital expenditure and escalating geopolitical tensions." But according to Todorova, that pain may be the price of opportunity. "The current price weakness presents an opportunity to start accumulating."
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0424">Benzinga Pro</a> data reveals Nvidia stock is down over 25% YTD, Alphabet about 18%, Microsoft over 10%, Amazon 18% and Meta is down over 13% YTD. Broad tech sector tracking ETFs such as the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) is down about 11% and the Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) is down almost 15% YTD.
<h2 class="wp-block-heading">How Trump And China Are Affecting Big Tech</h2>
President Donald Trump's latest pivot on China is also turning heads. "The Trump administration&#8217;s softened stance on China and the temporary pause on sweeping tariffs have helped fuel a short-term rally in Big Tech stocks," Todorova told Benzinga.
With Trump calling the 145% tariff "too high" and likely to come down "substantially," hopes of a de-escalation are reviving bullish spirits. "A substantial easing on tariffs toward China could restore confidence in these companies&#8217; growth trajectories."
Still, Todorova notes the picture isn't all rosy. "Despite temporary exemptions on electronics, the threat of broader tariffs, including those targeting semiconductors still looms." Nvidia, in particular, faces headwinds: "Export bans on Nvidia and AMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) chips have already triggered sharp declines."
The bottom line? 
"Often some of the market's strongest rebounds occur after sharp declines," notes Todorova, and for investors with "a longer time horizon and a steady hand," these oversold names may be a rare tech clearance sale.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44934241/us-tech-in-tariff-twilight-zone-says-dan-ives-nvidia-chip-restrictions-in-china-h">US Tech In Tariff &#8216;Twilight Zone&#8217; Says Dan Ives: Nvidia Chip Restrictions In China, Huawei Steps Into The Void</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Exclusives

Tech

Trading Ideas

Interview

AMZN

GOOG

GOOGL

MSFT

NVDA

EXCLUSIVE: Nvidia, Alphabet, Microsoft, Amazon, Meta - Now In The Bargain Bin After Being 'Heavily Sold Off', Says Expert

Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) just took a $50 price target cut from Goldman Sachs, but analysts still have faith in the tech giant&#8217;s efforts <a href="https://www.benzinga.com/topic/artificial-intelligence">to monetize artificial intelligence</a>.
What Happened: The Redmond, Washington-based company still ranks among the most compelling in the software industry despite <a href="https://www.benzinga.com/earnings">potential near-term headwinds</a>, analysts say.
In a note shared Thursday, Goldman Sachs&#8217; Kash Rangan reiterated a Buy rating on Microsoft while lowering the 12-month price target from $500 to $450. This reflects an adjustment of valuation multiples amid macroeconomic uncertainty.
At Wednesday&#8217;s closing price of $374.39, Goldman's new $450 price target implies a 20.2% upside.
Goldman sees divergent outcomes across Microsoft&#8217;s business lines as customers grapple with volatile economic conditions. A key area of focus is Azure, the company&#8217;s cloud computing platform and a cornerstone of its AI strategy.
For the fiscal third quarter of 2025, Goldman expects Azure growth of 31% in constant currency, slightly above the FactSet consensus of 30%, and an overall revenue figure of $68.6 billion, up 11% year over year, in line with consensus. 
Earnings per share are projected at $3.23, marginally higher than Wall Street's estimate of $3.21.
Yet Goldman is cautious about Microsoft&#8217;s fiscal year 2026 (FY26) outlook. While it currently projects 35% growth in non-AI revenue for Azure in FY26, up from 10% in FY25, Rangan acknowledged "some downside risk" if non-AI growth levels off.
Despite some moderation in non-AI workloads, the analyst still sees traction in generative AI demand. As new capacity ramps up, usage shifts toward applications.
See Also: <a href="https://www.benzinga.com/news/legal/25/04/44975360/geoffrey-hinton-ex-openai-insiders-and-top-ai-experts-sound-alarm-on-openais-restructuring-warn-it-could-strip-public-of-oversight-betray-agi-mission">Geoffrey Hinton, Ex-OpenAI Insiders, And Top AI Experts Sound Alarm On OpenAI&#8217;s Restructuring</a>
<h3 class="wp-block-heading">Capital Expenditures And Guidance Ambiguity</h3>
Investors are also looking for guidance clarity on FY26 CapEx, especially after reports of leasing adjustments and cancellations. 
Goldman maintains its forecast of 20% growth in capital expenditures, drawing confidence from Microsoft's historical willingness to invest through downturns.
Yet, the firm anticipates that Microsoft may delay formal spending guidance until its fourth-quarter earnings report, pending more clarity on U.S. trade policy and tariffs.
<h3 class="wp-block-heading">Generative AI Momentum Keeps Bulls Engaged</h3>
Even with the lower price target, Goldman views Microsoft as a long-term winner in the AI race.
Analysts highlight the company's positioning across all cloud layers—infrastructure, platforms, and applications—and its unique advantage in monetizing generative AI through services like GitHub Copilot, Microsoft 365 Copilot, and Azure OpenAI Services.
&#8220;We continue to believe that as Gen-AI moves from the Infrastructure layer to the Platform/Application layers, Microsoft is well positioned to capitalize on this shift as the only hyperscaler with a broad base of business applications,&#8221; the report said. 
Goldman forecasts FY25 revenue of $277.1 billion, up 12% year over year, and EPS of $13.15, closely aligned with consensus estimates.
What&#8217;s Next: The tech giant is set to report its fiscal third-quarter 2025 earnings on Wednesday, April 30.
Looking into fiscal 2026, Goldman sees earnings growth accelerating from +11% to +17% in 2025, helped by the transition from heavy AI infrastructure spending to higher-margin AI inference.
"Microsoft benefits from the higher margin inference phase of AI and the company comes out of a period of extreme capital intensity," the note said, suggesting a more profitable cycle ahead.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44977039/top-wall-street-forecasters-revamp-alphabet-expectations-ahead-of-q1-earnings">Top Wall Street Forecasters Revamp Alphabet Expectations Ahead Of Q1 Earnings</a></li>
</ul>
Image: Shutterstock

Analyst Color

Goldman Trims Microsoft Price Target, Sticks With Bullish Gen-AI Growth Thesis

<a href="https://pr.report/9qg0">Amaze Holdings, Inc.</a> (NYSE:<a href="https://www.benzinga.com/stock/AMZE#NYSE">AMZE</a>) ("Amaze" or the "Company"), a global leader in creator-powered commerce, today announced the appointment of <a href="https://pr.report/9qg1">Ezra Rosensaft</a> as its Chief Financial Officer ("CFO").
An accomplished finance executive, Rosensaft brings over two decades of strategic leadership in corporate finance, public market navigation, and scaling digital platforms across the media and technology landscape, experience that aligns directly with Amaze's mission to lead in creator-powered commerce. Most recently, he served as CFO at IDW Media, where he led the finance organization and drove strategic growth initiatives across operations, partnerships, and capital markets.
In his role as CFO, Rosensaft will oversee Amaze's financial strategy, ensuring the company is well-positioned to capitalize on emerging opportunities while also building out a long-term, sustainable capital structure that supports the Company's growth ambitions to become a profitable, high-growth SaaS business in the years to come.

Management

AMZE

Amaze Welcomes Ezra Rosensaft As Chief Financial Officer

<a href="https://pr.report/9qar">Amaze Holdings, Inc.</a> (NYSE:<a href="https://www.benzinga.com/stock/AMZE#NYSE">AMZE</a>) ("Amaze" or the "Company"), a global leader in creator-powered commerce, today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2024, which was filed on March 31, 2025 with the Securities and Exchange Commission, its audited financial statements contained an unqualified audit opinion from its independent registered public accounting firm that included an explanatory paragraph related to the Company's ability to continue as a going concern.

Amaze Holdings Receives Unqualified Audit Opinion With Going Concern Warning In 2024 Annual Report, Highlighting Financial Uncertainty Despite Auditor Approval

Sentinel Brokers Company, Inc. ("Sentinel"), a FINRA-registered broker-dealer and a subsidiary of DSS, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DSS#NYSE">DSS</a>), is pleased to announce that it has received approval from the Financial Industry Regulatory Authority (FINRA) to act as an underwriter and selling group member for corporate securities offerings.
This regulatory milestone significantly enhances Sentinel's capabilities in the capital markets, enabling the firm to participate more fully in initial public offerings (IPOs), follow-on offerings, and a wide array of corporate financing transactions. The approval underscores Sentinel's strategic growth and positions the company to better serve clients seeking capital through public market channels.
"FINRA's approval represents a pivotal advancement in our firm's trajectory," said Joseph Lawless, Founder and Chief Executive Officer of Sentinel Brokers Company, Inc. "It expands our scope beyond fixed income and equity market making and empowers us to more effectively support corporate issuers and institutional clients across the capital formation process."
Established in 1996, Sentinel has earned a reputation for excellence in institutional fixed income trading. In 2021, the firm broadened its offerings to include equity market-making. Now, with underwriting and selling group authority, Sentinel is poised to offer clients a fully integrated suite of services across multiple asset classes.
As a subsidiary of DSS, Inc.—a diversified, multinational company operating across various business divisions—Sentinel benefits from the strategic support and operational scale of a broader corporate ecosystem.

Sentinel Brokers Company, A Subsidiary Of DSS, Receives Approval From The Financial Industry Regulatory Authority To Act As An Underwriter And Selling Group Member For Corporate Securities Offerings

Valero Energy Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLO#NYSE">VLO</a>) shares are trading lower premarket on Thursday after the company reported a&nbsp;first-quarter&nbsp;sales of $30.26 billion, beating the analyst&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43330987/valero-energy-reports-2024-fourth-quarter-and-full-year-results" rel="noreferrer noopener">consensus estimate of&nbsp;$28.68 billion</a>.
The Refining segment posted an adjusted operating income of&nbsp;$605&nbsp;million, compared to $1.8 billion in the prior year quarter. During this quarter, refining throughput volumes&nbsp;averaged 2.8&nbsp;million barrels per day.
Adjusted operating income from the Ethanol segment stood at&nbsp;$20 million, down from&nbsp;$39 million&nbsp;in the&nbsp;first quarter&nbsp;of 2024. Production volumes averaged 4.5&nbsp;million gallons per day in the quarter.
The Renewable Diesel segment recorded an operating loss&nbsp;of&nbsp;$141&nbsp;million vs. operating income of $190 million in the prior year quarter. Segment sales volumes averaged 2.4&nbsp;million gallons per day during the quarter.
Adjusted EPS of&nbsp;$0.89 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the consensus estimate of&nbsp;$0.42.</a>
Valero returned&nbsp;$633&nbsp;million&nbsp;to stockholders, comprising&nbsp;$356&nbsp;million&nbsp;in dividends and&nbsp;$277&nbsp;million&nbsp;worth of share repurchases.
Valero ended the quarter with&nbsp;$8.5&nbsp;billion&nbsp;of total debt and&nbsp;$4.6&nbsp;billion&nbsp;of cash and cash equivalents.
On January 16, 2025, Valero announced an increase in its quarterly cash dividend on common stock <a href="https://www.benzinga.com//node/43041015" target="_blank" rel="noreferrer noopener">from $1.07 to $1.13 per share.</a>
Investors can gain exposure to the stock via&nbsp;VanEck Oil Refiners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRAK#NYSE">CRAK</a>) and Invesco Energy Exploration &amp; Production ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PXE#NYSE">PXE</a>).
Price Action: VLO shares are trading lower by 0.4% at $114.00 premarket at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/02/43894083/bank-of-montreal-expands-investment-offerings-with-new-etns-bitcoin-bet" target="_blank" rel="noreferrer noopener">Bank Of Montreal Expands Investment Offerings With New ETNs, Bitcoin Bet</a></li>
</ul>
Photo: Shutterstock

Large Cap

CRAK

PowerShares ETF Trust Dynamic Energy Exploration & Production Port

Valero Posts Higher-Than-Expected Profit Despite Sharp Refining Margin Decline

Carter Bankshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARE#NASDAQ">CARE</a>) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.28 by 14.29 percent. This is a 33.33 percent increase over earnings of $0.24 per share from the same period last year. The company reported quarterly sales of $37.04 million which beat the analyst consensus estimate of $34.90 million by 6.12 percent. This is a 10.68 percent increase over sales of $33.46 million the same period last year.

Earnings Beats

CARE

Carter Bankshares Q1 Adj. EPS $0.32 Beats $0.28 Estimate, Sales $37.04M Beat $34.90M Estimate

Collaboration brings together two leaders in ambulatory ECG recording and analysis
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heartbeam.com%2F&amp;esheet=54242849&amp;newsitemid=20250424671250&amp;lan=en-US&amp;anchor=HeartBeam%2C+Inc.&amp;index=1&amp;md5=301e7944ad32d33f512431db602073d0">HeartBeam, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAT#NASDAQ">BEAT</a>), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced a strategic collaboration with <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.accurkardia.com%2F&amp;esheet=54242849&amp;newsitemid=20250424671250&amp;lan=en-US&amp;anchor=AccurKardia&amp;index=2&amp;md5=f123a1fb0bbd1ac7b2b6b3ce3c18b3cc">AccurKardia</a>, an innovator in ECG-based diagnostics technology, bringing together two innovation leaders in ambulatory electrocardiogram (ECG) recording and analysis. The initial collaboration aims to enhance the accessibility of cardiac monitoring solutions and will focus on making AccurKardia's FDA-cleared ECG analysis software, AccurECG&#x2122;, available on HeartBeam's devices.&#x2A;
"This collaboration is a major step forward in delivering a more accessible and scalable solution for remote cardiac monitoring," said Robert Eno, Chief Executive Officer of HeartBeam. "AccurKardia shares our mission of improving cardiac outcomes through technological innovation, and together we can accelerate the delivery of unprecedented cardiac insights to individuals and physicians outside of a medical facility."

Biotech

BEAT

HeartBeam And AccurKardia Enters Strategic Collaboration To Advance Cardiac Monitoring Innovation

SurgePays, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) ("SurgePays" or the "Company"), a wireless and point-of-sale technology company, announced today the completion of its nationwide launch on the AT&amp;T network, following full integration as a mobile virtual network operator (MVNO). The milestone positions SurgePays to aggressively scale both its direct-to-consumer wireless services and its infrastructure platform as a mobile virtual network enabler (MVNE).
SurgePays has already shipped over 250,000 SIM cards to customers and retail partners across the country. With 500,000 additional SIM cards on order, the Company is ramping to meet strong demand across both its LinkUp Mobile brand and wholesale MVNE partner network.
The cutover to the AT&amp;T network, completed April 1, marks the final milestone in the MVNO integration process. This follows months of successful testing and phased migrations of prepaid subscribers, culminating in full validation of provisioning, billing and API systems by AT&amp;T.

SURG

SurgePays Announces The Completion Of Its Nationwide Launch On The AT&T Network, Following Full Integration As A Mobile Virtual Network Operator

SHANGHAI, April 24, 2025 /PRNewswire/ -- Hesai Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>), the global leader in lidar technology for automotive mobility and robotic applications, today announced that its long-range, automotive-grade AT128 lidar has been selected as the primary lidar solution for all three mass production models of the new seventh-generation Robotaxi unveiled by Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>), a global leader in the large-scale commercialization of autonomous mobility. Each vehicle will be equipped with four Hesai's AT128 lidar sensors, demonstrating Hesai's critical role in enabling advanced autonomous driving capabilities.

HSAI

PONY

Hesai Group's Automotive-Grade AT128 Lidar Selected As Primary Lidar Solution For All Three Mass Production Models Of New Seventh-Generation Robotaxi Unveiled By Pony AI

<a href="https://www.globenewswire.com/Tracker?data=qBFTfCsbizBoD8zg4us3MQUG_D3yibdc4V_kIlWdjaTguTdNbiqETPLf9saoFRWOjvmdBrLS3DKTIMiT76ELFaedhc_jc0t0oqnNfycVQvsoqipkJG7v2b58VakC5103">KULR Technology Group, Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KULR#NYSE">KULR</a>) (the "Company" or "KULR"), a global leader in advanced energy management solutions, today announced a strategic collaboration with <a href="https://www.globenewswire.com/Tracker?data=4n0fq6AEpZ2nraBEjWX8nok4Fp8nTyUbSqacOVmhR2e7R2mpumAuhKYVHlB9Wqeo8g6Ht71sPIkG0g2cNWHdgw==">AstroForge</a>, an asteroid resource extraction pioneer, to develop a custom 500 watt-hour (Wh) KULR ONE Space (K1S) battery pack. This partnership highlights the surging demand for reliable high-performance battery systems in the growing space battery market, projected to expand from $3.9 billion to $6.35 billion by 2030, according to <a href="https://www.globenewswire.com/Tracker?data=u6gD8zwgQ5wwUngoRMOglhaWqnitWS45Ty7NXIn407d3qVouo9U7HooQub3gKkH8ZK_c5lzPEz_9yL3b4qPOIkQrx_MPVs_kfOeD0a0MagqFmKyc1oqhRqrl4z2kdUyO4Kr_YzjR5IIRj4y2fPajrQ==">Virtue Market Research</a>.
The new 500Wh K1S design leverages KULR's established modules and NASA JSC 20793-compliant architectures to deliver a fast-to-market solution tailored to AstroForge's mission-critical needs. Built using NASA-approved cells, validated under WI-37 screening processes, the K1S pack showcases KULR's engineering prowess in optimizing the design for maximum volumetric and gravimetric energy density. Paired with KULR's advanced Battery Management System, the solution meets AstroForge's stringent functional, mechanical, and interface requirements while ensuring uncompromised safety and performance in space.
This collaboration builds on KULR's proven K1S platform&nbsp;— launched as the first commercial-off-the-shelf lithium-ion battery series fully compliant with NASA safety standards&nbsp;— demonstrating its adaptability to the unique challenges of cutting-edge space missions. The result is a scalable high-efficiency energy solution that accelerates deployment and enhances mission reliability.
"This iteration reflects the third design format of the KULR ONE Space architecture and will focus on energy density and reliability," said Dr. Will Walker, Chief Technology Officer of KULR Technology Group. "From compact CubeSats to complex resource extraction missions, our modular NASA-compliant designs provide the flexibility and performance our partners demand in a constantly evolving space landscape."
Robyn Ringuette, Chief Operating Officer of AstroForge, highlighted the partnership's impact: "KULR's expertise in working with NASA-approved architectures and delivering a customized solution in record time was a game-changer for our program. Their ability to maximize energy density while meeting our exact specifications ensured we could stay on schedule without sacrificing safety or performance, key to achieving our mission objectives."
The partnership signals a strengthening network of relationships between KULR and trailblazing companies in the space industry, as demand for innovative energy solutions continues to rise. By blending proven technology with agile design capabilities, KULR is solidifying its leadership in the space battery market, empowering customers to succeed in the most demanding environments.

KULR

KULR Technology Enters Strategic Collaboration With Astroforge To Develop A Custom 500 Watt-Hour KULR ONE Space Battery Pack.

Esquire Financial Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESQ#NASDAQ">ESQ</a>) reported quarterly earnings of $1.33 per share which beat the analyst consensus estimate of $1.31 by 1.53 percent. This is a 10.83 percent increase over earnings of $1.20 per share from the same period last year.

Esquire Financial Hldgs Q1 Adj. EPS $1.33 Beats $1.31 Estimate

<ul>
<li>Ferring expands production of ADSTILADRIN with new Parsippany, NJ, facility, adding to existing manufacturing sites in Kuopio, Finland</li>
<li>Capacity expansion and diversification of manufacturing footprint further ensures stable and sustainable supply to meet the anticipated growth in global demand for ADSTILADRIN</li>
<li>Milestone prompts final $200 million payment from Royalty Pharma</li>
</ul>
Ferring Pharmaceuticals announced today the U.S. Food and Drug Administration (FDA) approved a state-of-the-art drug product manufacturing hub in Parsippany, NJ, for its intravesical non-replicating gene therapy ADSTILADRIN&#xAE; (nadofaragene firadenovec-vncg). The approval expands Ferring's manufacturing capabilities to three cutting-edge sites dedicated to bringing ADSTILADRIN to patients and secures a final $200 million payment from Royalty Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPRX#NASDAQ">RPRX</a>) as part of a royalty-based financing agreement <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fferringusa.com%2F%3Fpress%3Droyalty-pharma-and-ferring-pharmaceuticals-enter-into-us-500-million-royalty-agreement-for-new-intravesical-gene-therapy-adstiladrin-nadofaragene-firadenovec-vncg&amp;esheet=54242093&amp;newsitemid=20250424910916&amp;lan=en-US&amp;anchor=announced+in+2023&amp;index=1&amp;md5=a6e5cb251b736a868f536b3d9f50ebbf">announced in 2023</a>.
ADSTILADRIN is the first and only intravesical non-replicating gene therapy approved by the FDA for patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors (±Ta/T1). Bladder cancer is the sixth most diagnosed cancer in the United States, and the majority of patients are diagnosed with non-muscle invasive disease.

RPRX

FDA Approves Second Drug Product Manufacturing Facility For ADSTILADRIN; Ferring Secures Final $200M Payment From Royalty Pharma

PepsiCo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) reported the first-quarter FY25 earnings on Thursday.
The food and beverage giant clocked a first-quarter FY25 <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/77476/000007747625000022/q120258-kxexhibit991.htm" rel="noreferrer noopener">sales decline</a> of 1.8% year-on-year to $17.92 billion, beating the analyst consensus estimate of $17.77 billion.
Adjusted EPS of $1.48 missed the <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">consensus estimate of $1.49</a>.
Net revenue from PepsiCo Foods North America (PFNA) decreased by 1% year over year, PepsiCo Beverages North America (PBNA) remained flat, and International Beverages Franchise (IB Franchise) gained 3%.
Also Read: <a target="_blank" href="https://www.benzinga.com//node/44825498" rel="noreferrer noopener">PepsiCo Still A Buy? Not Anymore As Analysts' Run Out Of Answers'</a>
Latin America Foods (LatAm Foods) sales slumped 12% year over year, and Europe, Middle East and Africa (EMEA) and Asia Pacific sales slipped 2%.
Gross profit remained nearly flat at $9.99 billion, with a gross margin of 55.7%. Operating margin contracted by 40 basis points to 14.4%, and operating income for the quarter decreased 4.9% to $2.58 billion.
The company held $8.35 billion in cash and equivalents as of March 22. Cash used in operating activities for the quarter totaled $(973) million.
Chairman and CEO&nbsp;Ramon Laguarta said, "As we look ahead, we expect more volatility and uncertainty, particularly related to global trade developments, which we expect will increase our supply chain costs. At the same time, consumer conditions in many markets remain subdued and similarly have an uncertain outlook."
Outlook FY25: PepsiCo cut its adjusted EPS outlook to $7.92, much lower than the estimate of $8.27 and a low-single-digit increase in organic revenue.
PepsiCo sees a core annual effective tax rate of approximately 20%.
The company expects total cash returns to shareholders to be approximately $8.6 billion, consisting of dividends of $7.6 billion and share repurchases of $1.0 billion.
Price Action: PEP shares are trading lower by 2.17% at $147.01 in premarket at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/04/44961625/fda-targets-synthetic-food-dyes-in-sweeping-nutrition-overhaul" target="_blank" rel="noreferrer noopener">FDA Targets Synthetic Food Dyes In Sweeping Nutrition Overhaul</a></li>
</ul>
Photo via Shutterstock

PepsiCo CEO Warns Of Tariffs Led 'Increase In Supply Chain Costs,' Cuts Annual Profit Outlook

SSII

SS Innovations Announces Uplisting To Nasdaq: Expected To Commence On April 25, 2025 With Ticker SSII

Baird analyst David Manthey maintains Watsco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSO#NYSE">WSO</a>) with a Outperform and lowers the price target from $560 to $540.

Baird Maintains Outperform on Watsco, Lowers Price Target to $540

Press Releases

Deep Track Capital Sends Letter to Dynavax Technologies' Board of Directors

BridgeBio Announces CFO Succession

Health Care

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BridgeBio to Present Cardiovascular Outcomes Data in Patients with Variant and Wild-type Transthyretin Amyloid Cardiomyopathy (ATTR-CM) from the ATTRibute-CM Study at the ACC Annual Scientific Sessions

Comments

BridgeBio Pharma

ニュース

最新ニュース BridgeBio Pharma (NASDAQ:BBIO) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル